Aptose Biosciences Inc. (APTO) Nonoperating Income (Expense) USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Aptose Biosciences Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2024.
  • Aptose Biosciences Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $120 K, a 71.4% decline year-over-year.
  • Aptose Biosciences Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $849 K, a 28.1% decline year-over-year.
  • Aptose Biosciences Inc. annual Nonoperating Income (Expense) for 2023 was $1.15 M, a 47.5% increase from 2022.
  • Aptose Biosciences Inc. annual Nonoperating Income (Expense) for 2022 was $779 K, a 738% increase from 2021.
  • Aptose Biosciences Inc. annual Nonoperating Income (Expense) for 2021 was $93 K, a 82.5% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $849 K $120 K -$300 K -71.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.15 M $172 K -$231 K -57.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $1.38 M $234 K -$15 K -6.02% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.4 M $323 K +$215 K +199% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.18 M $420 K +$401 K +2111% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $779 K $403 K +$379 K +1579% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $400 K $249 K +$223 K +858% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $177 K $108 K +$90 K +500% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $87 K $19 K -$6 K -24% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $93 K $24 K -$22 K -47.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 $115 K $26 K -$19 K -42.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $134 K $18 K -$113 K -86.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $247 K $25 K -$283 K -91.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $530 K $46 K -$129 K -73.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 $659 K $45 K -$138 K -75.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $797 K $131 K +$3 K +2.34% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $794 K $308 K +$214 K +228% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $580 K $175 K +$111 K +173% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-23
Q3 2019 $469 K $183 K +$103 K +129% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $366 K $128 K +$61 K +91% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $305 K $94 K +$66 K +236% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $239 K $64 K +$23 K +56.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 $216 K $80 K +$11 K +15.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $205 K $67 K +$27 K +67.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $178 K $28 K -$5 K -15.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $183 K $41 K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 $69 K Jul 1, 2017 Sep 30, 2017 8-K 2019-03-12
Q2 2017 $40 K Apr 1, 2017 Jun 30, 2017 8-K 2019-03-12
Q1 2017 $33 K Jan 1, 2017 Mar 31, 2017 8-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.